期刊文献+

口服避孕药在PCOS中的应用 被引量:3

下载PDF
导出
摘要 复方口服避孕药(OCs)是多囊卵巢综合征(PCOS)患者最常用的药物之一,通过控制月经周期和降低雄激素水平而达到治疗目的。但PCOS是一种慢性疾病,需要长期治疗,PCOS患者又为代谢异常和心血管疾病等的高危人群,因而OCs在PCOS患者中长期使用的安全性受到关注。目前研究发现OCs有可能引起血脂增高,并增加血栓形成风险,但未发现对糖代谢的不利影响。OCs对卵巢癌有防护作用,但增加宫颈癌、乳腺癌的发病风险。长期使用OCs不影响女性生育能力。因此,在严格掌握好适应症和禁忌症的前提下,OCs在PCOS患者中长期使用是利大于弊、安全有效的。
作者 李琳 杨冬梓
出处 《现代妇产科进展》 CSCD 北大核心 2010年第9期707-709,712,共4页 Progress in Obstetrics and Gynecology
  • 相关文献

参考文献17

  • 1SperoffL,FritzMA.临床妇科内分泌学与不孕[M].李继俊主译.第7版.山东:山东科学技术出版社,2006:367-387.
  • 2中华医学会妇产科学分会内分泌学组.多囊卵巢综合征诊断与治疗专家共识.多囊卵巢综合征的常见问题与回答.多囊卵巢综合征诊治共识及解析(中华医学会继续医学教育教材)[M].中华医学电子音像出版社,2009:4-14.
  • 3Soares GM, Vieira CS, de Paula Martins W, et al. Metabolic and cardiovascular impact of oral contraceptives in polycystic ovary syndrome [ J ]. Int J Clin Pract,2009,63 : 160- 169.
  • 4Mastorakos G, Koliopoulos C, Deligeoroglu E,et al. Effects of two forms of combined oral contraceptives on carbohydrate metabolism in adolescents with polycystic ovary syndrome [ J ]. Fertil Steri1,2006,85:420-427.
  • 5Lopez LM, Grimes DA, Schulz KF. Steroidal contraceptives:effect on carbohydrate metabolism in women without diabetes mellitus[J]. Cochrane Database Syst Rev, 2009,7 : CDO06133.
  • 6Curtis KM, Mohllajee AP, Matins SL, et al. Combined oral contraceptive use among women with hypertensions:a systematic review[ J]. Contraception ,2006,73 : 179-188.
  • 7Kemmerern JM, Algra A, Grobbee DE. Third generation oral contraceptives and risk of venous thrombosis: meta-analysis [ J]. BMJ ,2001,323 : 131-134.
  • 8Seaman HE, Vries CS, Farmer RD. The risk of venous thromboembolism in women prescribed cyproterone acetate in combination with ethinyl estradiol:a nested cohort analysis and case-control study [ J ]. Hum Reprod, 2003, 18:522-526.
  • 9Collaborative group on epidemiological studies of ovarian cancer, Beral V, Doll R, et al. Ovarian cancer and oral contraceptives:collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls [ J ]. Lancet, 2008, 371:303-314.
  • 10International collaboration of epidemiological studies of cervical cancer, Appleby P, beral V, et al. Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies [J]. Lancet, 2007,370 : 1609-1621.

同被引文献35

  • 1陶莉莉,张玉珍,桑霞,曾蕾,禹安琪,陈靓芬.加减龙胆泻肝汤对肝经郁火型多囊卵巢综合征患者高雄激素血症的影响[J].中国中西医结合杂志,2006,26(9):838-841. 被引量:37
  • 2范光升.现代口服避孕药使用指南[J].中国计划生育学杂志,2007,15(6):378-381. 被引量:3
  • 3Braendle W,Kuhl H,Mueek A,el al.Does hormonal contraception increase the rish for tumors?[J].Ther Umsch,2009,66(2):129-135.
  • 4Ge Qs,Tian QJ,Tseng H,et al.Development of low-dose reproductive hormone therapies in China[J].Cynecol Endocrinol,2006,22(11):636-645.
  • 5Kauatiz AM,Miller PD,Rice VM,et al.Bone mineral density in women aged 25-35 years receiving depol medroxyprogesterone acetate; Recovery following discontinuation[J].Contraception,2006,74(2):90-99.
  • 6Albertazzi P,Botazzi M,Steel SA.Bone mineral density and depot medroxyprogesterone acetate[J].Contraception,2006,73(6):577-583.
  • 7Tao MH,Xu WH,Zheng W,et al.Oral contraception and IUD use and endometrial cancer; a population-based case-control study in shanghai,China[J].Int J Cancer,2006,119(9):2142-2147.
  • 8Kahlenbom C,Modugon F,Potter DM,et al.Oral contractive use as a rise factor for premenopausal breast cancer:a meta-analysia[J].Mayo Clin Proe,2006,81(10):1290-1320.
  • 9Haile RW,Thomas DC,McGuire V,et al.BRCAL and BRCA2 mutation carriers,oral contractive use,and breast cancer before age 50[J].Cancer Epidemiol Biomakers Prev,2006,15(10):1863-1870.
  • 10Vessey P,Painter R.Oral contraception use and cancer.Findings in a large cohort study[J].Br J Cancer,2006,95(3):385-389.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部